title: Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents.
authors.affiliation: Haemophilia Centre, Barts Health NHS Trust, Royal London Hospital, London, UK.
authors.forename: Sean
authors.initials: S
authors.lastname: Platton
authors.affiliation: Haemophilia Centre, Barts Health NHS Trust, Royal London Hospital, London, UK.
authors.forename: Louise
authors.initials: L
authors.lastname: Bowles
authors.affiliation: Queen Mary's School of Medicine and Dentistry, London, UK.|Wolfson Institute of Preventive Medicine, London, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: MacCallum
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests / Q000379:methods / Q000592:standards*; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D000069552:Rivaroxaban / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban
keywords: Coagulation; anticoagulants; haemostasis; laboratory haematology